Work

Phase II study of letrozole, abemaciclib and metformin in estrogen receptor-positive recurrent endometrial cancer

Year: 2025

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2025.04.503

Authors: Panagiotis Konstantinopoulos, Ningxuan Zhou, Richard Penson, Susana Campos, Carolyn Krasner, Alexi Wright, Rebecca Porter, Neil Horowitz, Sara Bouberhan, Hannah Sawyer, Lani Koppermann, Martin Hayes, Madeline Polak, Meghan Shea, Page Widick, Su-Chun Cheng, Cesar Castro, Ursula Matulonis, Elizabeth Lee

Institutions: Dana-Farber Cancer Institute, Harvard University, Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center, Beth Israel Deaconess Medical Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414650003

FWCI: 0.661

Cites:

Cited by: 1

Related to: 10